Opko Health
http://www.opko.com
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Opko Health
Scrip Asks...What Does 2023 Hold For Biopharma? Part 2: M&A And Partnering
Deal-making between big pharma and biotech looks set to rise with a looming patent cliff increasing the need for the former to replenish its pipelines. Meanwhile, biotechs need partners to help them advance amid the ongoing big freeze on raising cash on public markets.
Dealmaking Quarterly Statistics, Q2 2022
During Q2, biopharma merger and acquisition value reached $25.4bn and drew in $27.3bn in potential deal value from alliances. Device company M&A values reached $2.7bn, while in vitro diagnostic firms and research tools players completed M&A activity that totaled $534.3m.
2021 Global Biopharma R&D Productivity And Growth Ranking
A turbulent 2021: we are now in our eighth year of reviewing R&D productivity and corporate growth of the top 30 biopharma companies. While 2021 was dominated by the COVID-19 pandemic, biopharma as a whole had a good but not great year.
Japan Lifts Decades-Old Bans On Somatropin In Diabetes, IFNβ In Pregnancy
Japan cautiously lifts decades-old bans on somatropin’s use in diabetic patients and interferon beta 1a/1b in pregnant patients, judging benefits can outweigh risks and following requests from doctors and pharma firms to consider patients.
Company Information
- Industry
-
Pharmaceuticals
- Drug Delivery
- Generic Drugs
- Nutraceuticals
- Vaccines
-
Medical Devices
-
Diagnostic Imaging Equipment & Supplies
- Digital Imaging
-
Diagnostic Imaging Equipment & Supplies
-
Laboratory Testing Services
- Anatomical Pathology
-
In Vitro Diagnostics
- Chemistry, Immunoassay
- Molecular Diagnostics & Genetic Testing
- Therapeutic Drug Monitoring
-
Biotechnology
- Antisense, Oligonucleotides
- Large Molecule
- Pharmacogenetics-Pharmacogenomics
-
Drug Discovery Tools
-
Molecular Diversity
- Natural Products
-
Molecular Diversity
- Other Names / Subsidiaries
-
- ALS Distribuidora Limitada
- Bio-Reference Laboratories, Inc.
- Claros Diagnostics Inc.
- CURNA, Inc.
- Cytochroma, Inc.
- EirGen Pharma, Ltd.
- eXegenics, Inc.
- GeneDX
- Modigene
- Inspiro Medical Ltd.
- OURLab
- PROLOR Biotech, Inc.
- Prost-Data, Inc.
- Silcon Comércio
- Importacao E Exportacao de Produtos Farmaceuticos e Cosmeticos Ltda.
- Transition Therapeutics Inc.
- Waratah Pharmaceuticals Inc.
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice